ENETF yields 400000.00% · PFE yields 6.13%● Live data
📍 ENETF pulled ahead of the other in Year 1
Combined, ENETF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ENETF + PFE for your $10,000?
Ethernity Networks Ltd. provides technology solutions for telecom, mobile, security, and data center markets in Asia, Europe, Israel, and the United States. The company develops and delivers data processing technology and solutions for carrier Ethernet switching, including broadband access, mobile backhaul, carrier Ethernet demarcation, and data centers. It provides ENET flow processors for telco/cloud network; ACE-NIC40 SmartNIC, an open flow enabled software acceleration NIC; ACE-NIC40 SmartNIC, an open flow enabled software acceleration NIC; ACE-NIC50 SmartNIC, which offers 10/25G Ethernet connectivity and field-programmable gate array (FPGA) acceleration; ACE-NIC100 SmartNIC that provides flexible 10/25/40/100G Ethernet connectivity and programmable FPGA acceleration; ENET UEP-60, a programmable routing appliance for 5G, OpenRAN, and Network Edge; and ACE-NIC100 SmartNIC that provides flexible 10/25/40G/100G Ethernet connectivity and programmable FPGA acceleration. The company also offers ENET network appliances, such as ENET UEP-20 universal edge platform and ENET UEP-60 universal edge platform. In addition, it provides FPGA based networking and security solutions to telco/cloud equipment manufacturers and system integrators. The company was formerly known as Neracore Ltd. and changed its name to Ethernity Networks Ltd. in August 2004. Ethernity Networks Ltd. was incorporated in 2003 and is headquartered in Airport City, Israel.
Full ENETF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.